They quibble, joke and share knowing looks, finishing each other's thoughts and making snide comments—like many sisters. But a recent heated argument was unlike any other they've had, and it ended in a most surprising way.
Jan 22, 2014
0
1
The U.S. government is preparing to regulate the new field of hand and face transplants like it does standard organ transplants, giving more Americans who are disabled or disfigured by injury, illness or combat a chance at ...
Dec 26, 2013
0
0
A new analysis has found no evidence that children aged 6 to 11 years seeking a deceased donor lung transplant are disadvantaged in the current US lung allocation system. The findings, which are published in the American ...
Dec 12, 2013
0
0
A team of scientists that includes Saint Louis University researchers has identified a new way to intervene in the molecular and cellular cascade that causes fibrosis – a condition where the body's natural process of forming ...
Nov 10, 2013
0
0
(HealthDay)—Opsumit (macitentan) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a debilitating disease characterized by high blood pressure in the lung arteries.
Oct 23, 2013
0
0
The multidisciplinary transplant team at University Hospitals Leuven successfully preserved a set of donor lungs for over eleven hours with the help of a machine, the longest period ever reported. The lengthy preservation ...
Oct 16, 2013
0
0
(HealthDay)—Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.
Oct 9, 2013
0
0
A Yale-led study has identified a gene expression profile that can predict outcomes and lead to better treatment for one of the most lethal lung diseases, idiopathic pulmonary fibrosis (IPF). The study appears in Science ...
Oct 2, 2013
0
0
(HealthDay)—For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. ...
Aug 29, 2013
0
0
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study ...
Aug 28, 2013
0
0
